CASCADE®
Autologous Platelet System
Interest in fibrin clot techniques and the expanded application of growth factors in soft tissue and bone repair have led to the development of the CASCADE® Autologous Platelet System. Cascade employs platelets and their associated growth factors for clinical applications that require rapid healing and tissue regeneration. The Cascade system represents An Evolution In Platelet Therapy, producing PRFM that can be delivered arthroscopically and sutured into a repair site to stimulate a healing response. The PRFM implant represents a potentially more precise technique to deliver a more concentrated and volume stable fibrin matrix rich in platelets. Growth factors within the PRFM remain functionally viable throughout the Cascade process and are continually released over seven days.
The Cascade system is also available in separate forms for producing a Cascade Platelet-Rich Fibrin Membrane with improved biomechanical properties and the Cascade Platelet-Rich Plasma Therapy for the treatment of various tendonitis and tendinosis indications.
Only MTF has a completed offering of platelet-rich plasma therapies.
| |
|
| 910048 |
Cascade Autologous Platelet System, PRFM x2 |
| 910050 |
Cascade Autologous Platelet System, PRFM |
| 910058 |
Drucker General Purpose Centrifuge w/ Locking Lid |
| |
|
| |
|
| 910044 |
Cascade Autologous Platelet System, Membrane |
| 910060 |
Drucker General Purpose Centrifuge II w/ Locking Lid |
| |
|
| |
Click for Patient Info |
| 910046 |
Cascade Autologous Platelet System, PRP |
| 910058 |
Drucker General Purpose Centrifuge w/ Locking Lid |
| |
|
)
)
)
)
)
)
)